a manufacturer of cancer therapies
Industry Biotechnology
A.I.dvisor tells us that BYSI and APGE have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BYSI and APGE's prices will move in lockstep.
Ticker / NAME | Correlation To BYSI | 1D Price Change % | ||
---|---|---|---|---|
BYSI | 100% | -5.39% | ||
APGE - BYSI | 26% Poorly correlated | -5.41% | ||
XRTX - BYSI | 25% Poorly correlated | +5.24% | ||
NCNA - BYSI | 23% Poorly correlated | -7.10% | ||
SMMT - BYSI | 23% Poorly correlated | -2.93% | ||
NRXP - BYSI | 22% Poorly correlated | -12.03% | ||
More |
Ticker / NAME | Correlation To BYSI | 1D Price Change % |
---|---|---|
BYSI | 100% | -5.39% |
pharmaceuticals theme (167 stocks) | 8% Poorly correlated | +0.82% |
cancer theme (87 stocks) | 1% Poorly correlated | +0.89% |